Clinical impact of prevalence and severity of COPD on the decision-making process for therapeutic management of lung cancer patients
Open Access
- 5 February 2014
- journal article
- research article
- Published by Springer Nature in BMC Pulmonary Medicine
- Vol. 14 (1) , 14
Abstract
Recent studies suggest that coexistence of chronic obstructive pulmonary disease (COPD) might be independently related to a worse prognosis for lung cancer. However, because data on the substantial prevalence of COPD and its severity in Asian lung cancer patients remain limited, clinical impact of prevalence and severity of COPD among the population has not been fully evaluated. Furthermore, patients with COPD often have comorbidities. Thus, whether the decision-making process for therapeutic management of lung cancer patients might be independently affected by COPD remains elusive. Clinical impact of prevalence and severity of COPD were evaluated in 270 Japanese patients with newly diagnosed lung cancer who were sequentially registered and underwent bronchoscopy from August 2010 to July 2012 at Nagoya University hospital. Furthermore, to explore whether or not the severity of airflow obstruction might affect the decision to propose thoracic surgery with curative intent, we evaluated data from patients with lung cancer at stage 1A to 3A who underwent spirometry and bronchoscopy. The prevalence rate of COPD was 54.4% among Japanese patients with lung cancer who underwent bronchoscopy. The incidence of Global Initiative for Chronic Obstructive Lung Disease (GOLD) grades 1 and 2 was significantly higher than that of GOLD grade 3. Although COPD-related comorbidities were not independent factors for proposing thoracic surgery, the number of thoracic surgeries performed was significantly less in the COPD group than the non-COPD group. Multivariate analysis showed that more severe airway obstruction, advanced clinical staging, and higher age, were independent factors associated with the decision on thoracic surgery. We demonstrated a high prevalence of COPD among Japanese lung cancer patients. Based on the knowledge that severity of COPD is one of the most important factors in the therapeutic decision, comprehensive assessment of COPD at bronchoscopy might allow us to implement the optimum management for lung cancer patients.Keywords
This publication has 29 references indexed in Scilit:
- Lung Cancer in Chronic Obstructive Pulmonary Disease: Enhancing Surgical Options and OutcomesAmerican Journal of Respiratory and Critical Care Medicine, 2011
- ERS/ESTS clinical guidelines on fitness for radical therapy in lung cancer patients (surgery and chemo-radiotherapy)European Respiratory Journal, 2009
- COPD prevalence is increased in lung cancer, independent of age, sex and smoking historyEuropean Respiratory Journal, 2009
- Complex chronic comorbidities of COPDEuropean Respiratory Journal, 2007
- Global burden of COPD: risk factors, prevalence, and future trendsThe Lancet, 2007
- Chronic Obstructive Pulmonary Disease is Associated with Lung Cancer Mortality in a Prospective Study of Never SmokersAmerican Journal of Respiratory and Critical Care Medicine, 2007
- Projections of Global Mortality and Burden of Disease from 2002 to 2030PLOS Medicine, 2006
- Prevalence of COPD in Women Compared to Men Around the Time of Diagnosis of Primary Lung CancerChest, 2006
- Prognostic value of chronic obstructive pulmonary disease in 2994 cases of lung cancerEuropean Journal of Cardio-Thoracic Surgery, 2005
- Impact of COPD on pulmonary complications and on long-term survival of patients undergoing surgery for NSCLCLung Cancer, 2002